Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

ClinicalTrials.gov ID: NCT02886494

Public ClinicalTrials.gov record NCT02886494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient with Alzheimer's Disease or Vascular Dementia

Study identification

NCT ID
NCT02886494
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Charsire Biotechnology Corp.
Industry
Enrollment
80 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2016 (Actual)
Primary completion
Nov 1, 2018 (Actual)
Completion
Nov 1, 2018 (Actual)
Last update posted
Oct 13, 2022

2016 – 2018

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Clinical Research Consortium Tempe Arizona 85283 —
Woodland International Research Group Little Rock Arkansas 72211 —
Woodland Research Northwest, LLC Rogers Arkansas 72758 —
Pacific Research Network, LLC San Diego California 92103 —
NeuroTrials Research, Inc. Atlanta Georgia 30342 —
The Cognitive and Research Center of NJ Springfield New Jersey 07081 —
Advanced Memory Research Institute of NJ, PC Toms River New Jersey 08755 —
SPRI Brooklyn New York 11235 —
Wake Research Associates Raleigh North Carolina 27612 —
Neurology Diagnostics, Inc. Dayton Ohio 45459 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02886494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2022 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02886494 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →